By evaluating the IP-10 levels, this study not only provides data for identifying high-risk groups for sarcopenia development but also improves our knowledge on the underlying mechanisms involved in sarcopenia development in patients with primary HCC. This evidence concerns the gene CXCL10 and hepatocellular carcinoma.